Andrew Jackson

Andrew Jackson

Director of Finance/CFO at CALIDI BIOTHERAPEUTICS, INC.

Net worth: 425 $ as of 2026-06-29

57 year
Health Technology
Consumer Services

Profile

Mr. Andrew C.
Jackson
is a Chief Financial Officer & Secretary at Calidi Biotherapeutics, Inc. Mr. Jackson was previously employed as a Chief Financial Officer by Eterna Therapeutics, Inc., a Secretary, Chief Financial & Accounting Officer by Ra Medical Systems, Inc., a Chief Financial Officer by AltheaDx, Inc., and a Chief Financial Officer by Celladon Corp.
He received his undergraduate degree from the University of Minnesota and a graduate degree from San Diego State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-16 2,500 ( 0.07% ) 425 $ 2026-06-29

Andrew Jackson active positions

CompaniesPositionStart
CALIDI BIOTHERAPEUTICS, INC. Director of Finance/CFO 2023-10-29

Former positions of Andrew Jackson

CompaniesPositionEnd
ERNEXA THERAPEUTICS INC. Director of Finance/CFO 2023-05-03
CATHETER PRECISION, INC. Chief Executive Officer 2020-03-29
ALTHEADX INC Director of Finance/CFO 2018-03-31
Director of Finance/CFO 2016-02-29
See the detail of Andrew Jackson's experience

Training of Andrew Jackson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Andrew Jackson